Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer Inc. (PFE) Q3 2025 Earnings Call Transcript
03:56pm, Tuesday, 04'th Nov 2025
Pfizer Inc. ( PFE ) Q3 2025 Earnings Call November 4, 2025 10:00 AM EST Company Participants Francesca DeMartino - Chief Investor Relations Officer Albert Bourla - Chairman of the Board & CEO David De
Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It
03:04pm, Tuesday, 04'th Nov 2025
Pfizer Inc's (NYSE:PFE) lawsuit. Novo Nordisk A/S' (NYSE:NVO) counterbid.
Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb
02:45pm, Tuesday, 04'th Nov 2025
Adding more drama to Metsera Inc.'s (NASDAQ:MTSR) acquisition deal, Novo Nordisk A/S (NYSE:NVO) increased the deal proposal to $62.20 per share in cash, up from $56.50.
Why Metsera stock's 20% surge signals a fierce Pfizer-Novo Nordisk bidding war
01:02pm, Tuesday, 04'th Nov 2025
Metsera stock (NASDAQ: MTSR) surged roughly 20% on Tuesday after the obesity-focused biotech announced that Novo Nordisk's revised $10 billion acquisition proposal has been deemed “superior” to Pf
Novo Nordisk tops Pfizer in bidding war for obesity startup Metsera
12:27pm, Tuesday, 04'th Nov 2025
Novo Nordisk (NYSE:NVO) has outbid Pfizer Inc (NYSE:PFE, ETR:PFE) in a heated contest for obesity-focused biotech Metsera (NASDAQ:MTSR), with the Danish drugmaker's revised offer valuing the company a
Pfizer and Novo Nordisk both raise bids for Metsera
12:18pm, Tuesday, 04'th Nov 2025
CNBC's David Faber breaks down the latest details about a bidding war between Pfizer and Novo Nordisk for Metsera.
Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools
12:15pm, Tuesday, 04'th Nov 2025
Pfizer posts Q3 earnings beat and raises EPS guidance, but weaker COVID product sales weigh on overall revenue momentum.
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo
11:29am, Tuesday, 04'th Nov 2025
A Delaware judge said on Tuesday she did not see in a preliminary evaluation the need to involve the court in the bidding war for Metsera between Pfizer and Novo Nordisk, but did schedule another hear
Pfizer reports strong Q3 earnings, raises full-year profit guidance
11:25am, Tuesday, 04'th Nov 2025
Pfizer Inc (NYSE:PFE, ETR:PFE) reported third quarter financial results that topped Wall Street expectations despite a year-over-year drop in earnings and sales, while raising its full-year profit gu
Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings
11:01am, Tuesday, 04'th Nov 2025
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare
Metsera said it received a revised acquisition offer from Novo Nordisk that it called superior to Pfizer's bid
09:58am, Tuesday, 04'th Nov 2025
The new offer constitutes a superior company proposal to Pfizer's bid, Metsera said.
Pfizer's Q3 Earnings Beat on Top and Bottom Lines
09:54am, Tuesday, 04'th Nov 2025
Pfizer (NYSE: PFE) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue of $16.65 billion versus $16.50 billion expected.
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates
09:53am, Tuesday, 04'th Nov 2025
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 400 points on Tuesday.
Metsera says Novo Nordisk's new bid for obesity drugmaker is ‘superior' to revised Pfizer offer
09:40am, Tuesday, 04'th Nov 2025
Metsera said Novo Nordisk's new bid for the obesity biotech is "superior" to a revised offer from Pfizer, escalating a heated tussle over the startup between the two pharmaceutical giants. Novo Nord
Pfizer's revenue falls as COVID sales and vaccine recommendations continue to fade
09:30am, Tuesday, 04'th Nov 2025
The full-year outlook was lifted, but the stock lost ground.
